Cleveland Clinic, G42 to drive global AI adoption in healthcare

Photo: Westend61/Getty Images

Cleveland Clinic and G42, an artificial intelligence-focused technology group headquartered in Abu Dhabi, United Arab Emirates (UAE), are teaming up to drive AI-powered advancements in healthcare, both in the U.S. and globally.

As part of this initiative, the organizations will form a joint task force to evaluate and accelerate potential projects and collaborative opportunities aimed at advancing AI adoption in healthcare.

According to Cleveland Clinic, G42 is known for innovation in AI, digital infrastructure ang big data analytics across a range of industries. Its healthcare portfolio company, M42, spans 480 clinics in 26 countries and leads advancements such as the Emirati Genome Program, the world’s largest genomics initiative, and Malaffi, Abu Dhabi’s Health Information Exchange.

WHAT’S THE IMPACT

As part of the collaboration, Cleveland Clinic and G42 will explore and implement AI-driven healthcare initiatives they think have the potential to enhance medical innovation and drive operational efficiencies. 

Peng Xiao, Group CEO of G42, said AI’s potential to transform the healthcare industry remains “largely untapped.”

“From deciphering the source code of life – our genome – to optimizing efficiencies across the entire patient journey, AI is paving the way for a future where care is not only more precise but also deeply personalized and preventative,” he said.

In the U.S., physicians are warming to the use of artificial intelligence in healthcare. The American Medical Association surveyed physicians in February, finding about 35% of them expressed more enthusiasm than concern – up from the 30% who felt the same last year. The portion of physicians whose concerns exceeded their enthusiasm for health AI decreased to 25% in 2024 from 29% in 2023, and about two in five physicians remain equally excited and concerned about health AI, with almost no change between 2023 and 2024.

In particular, physicians are increasingly intrigued by AI’s power as a clinical assistant and in its potential to reduce administrative burdens, enhance diagnostic accuracy and personalize treatments.

THE LARGER TREND

More than half of health system leaders and insurance executives are calling AI an “immediate priority,” and 73% of organizations said they were growing their financial commitments to the technology, according to a 2023 Define Ventures survey.

Seventy-three percent of organizations have established governance structures, which can align AI incentives with organizational values.

There’s $9.8 billion in potential savings through AI-powered automation in the revenue cycle, according to statistics provided by TruBridge, a consultant and IT services provider, at the HFMA annual conference in Nashville in June 2023. Nine percent of all claims are rejected in error or from prior authorization denials; 23.9% of denials are due to eligibility issues.

Jeff Lagasse is editor of Healthcare Finance News.
Email: jlagasse@himss.org
Healthcare Finance News is a HIMSS Media publication.